Citation data

OpenCitations

Works that cite this article, indexed by OpenCitations.

38 resultsUpdated October 20, 2026
1

Association between changes in thyroid hormones and incident type 2 diabetes using joint models of longitudinal and time-to-event data: more than a decade follow up in the Tehran thyroid study

Frontiers in Endocrinology 15 (2024)

Alireza Amirabadizadeh; Ladan Mehran; Atieh Amouzegar; Samaneh Asgari; Davood Khalili; Fereidoun Azizi

2

Nonparametric estimation of bivariate cumulative distribution function

Arabian Journal of Mathematics 13(3) (2024)

Behzad Mansouri; Azam Rastin; Habib Allah Mombeni

3

Evaluation of the effectiveness of the Iran-package of essential non-communicable disease (IraPEN) program in reducing cardiovascular disease risk in pilot areas

BMC Public Health 25(1) (2025)

Somayeh Derakhshan; Davood Khalili; Alireza Mahdavi; Seyed-Saeed Hashemi-Nazari; Amir Kavousi; Fatemeh Hadavandsiri; Afshin Ostovar; Koorosh Etemad

4

Association of Lipid Profile With Cardiovascular Diseases and All‐Cause Death: A 2‐Decade Follow‐Up of the Tehran Lipid and Glucose Study

Journal of the American Heart Association 14(15) (2025)

Azra Ramezankhani; Fereidoun Azizi; Farzad Hadaegh

5

Different Metabolic Phenotypes of Obesity and 2 Decades Risk of Cardio–Renal–Metabolic Multimorbidity: Tehran Lipid and Glucose Study

Journal of the American Heart Association 14(18) (2025)

Danial Molavizadeh; Soroush Masrouri; Farzad Esmaeili; Fereidoun Azizi; Farzad Hadaegh

6

Association of trajectory of body shape index with all-cause and cause-specific mortality: 18 years follow-up

Frontiers in Endocrinology 14 (2023)

Elham Kazemian; Ladan Mehran; Safdar Masoumi; Atieh Amouzegar; Fereidoun Azizi

7

Association of ideal cardiovascular health metrics with incident low estimated glomerular filtration rate: More than a decade follow-up in the Tehran Lipid and Glucose Study (TLGS)

PLOS ONE 19(2) (2024)

Fatemeh Alizadeh; Maryam Tohidi; Mitra Hasheminia; Firoozeh Hosseini-Esfahani; Fereidoun Azizi; Farzad Hadaegh

8

Factors associated with smoking intensity among adult smokers: findings from the longitudinal cohort of the Tehran lipid and glucose study

BMC Public Health 23(1) (2023)

Marjan Abbasi-Dokht-Rafsanjani; Samaneh Hosseinzadeh; Enayatollah Bakhshi; Fereidoun Azizi; Davood Khalili

9

Sex differences in risk factors for coronary heart disease events: a prospective cohort study in Iran

Scientific Reports 13(1) (2023)

Azra Ramezankhani; Fereidoun Azizi; Farzad Hadaegh

10

Effect of family history of diabetes and obesity status on lifetime risk of type 2 diabetes in the Iranian population

Journal of Global Health 12 (2022)

Azra Ramezankhani; Ali Siamak Habibi-Moeini; Seyed Saeed Tamehri Zadeh; Fereidoun Azizi; Farzad Hadaegh

11

Association of dietary fatty acids and the incidence risk of cardiovascular disease in adults: the Tehran Lipid and Glucose Prospective Study

BMC Public Health 20(1) (2020)

Parvin Mirmiran; Zeinab Houshialsadat; Zahra Bahadoran; Sajad Khalili-Moghadam; Farhad Sheikholeslami; Fereidoun Azizi

12

Differences in the impact of impaired glucose status on clinical outcomes in younger and older adults: Over a decade of follow-up in the Tehran lipid and glucose study

Frontiers in Cardiovascular Medicine 9 (2022)

Samaneh Asgari; Soroush Masrouri; Davood Khalili; Fereidoun Azizi; Farzad Hadaegh

13

Impact of secondhand smoke exposure in former smokers on their subsequent risk of coronary heart disease: evidence from the population-based cohort of the Tehran Lipid and Glucose Study

Epidemiology and Health 42 (2020)

Masoumeh Sadeghi; Maryam S. Daneshpour; Soheila Khodakarim; Amir Abbas Momenan; Mahdi Akbarzadeh; Hamid Soori

14

Anthropometric indices and the risk of incident sudden cardiac death among adults with and without diabetes: over 15 years of follow-up in The Tehran Lipid and Glucose Study

Diabetology & Metabolic Syndrome 13(1) (2021)

Seyyed Saeed Moazzeni; Seyed Saeed Tamehri Zadeh; Samaneh Asgari; Fereidoun Azizi; Farzad Hadaegh

15

Dietary acid load and risk of cardiovascular disease: a prospective population-based study

BMC Cardiovascular Disorders 21(1) (2021)

Parvin Mirmiran; Zeinab Houshialsadat; Zahra Bahadoran; Sajjad Khalili‑Moghadam; Mohammad Karim Shahrzad; Fereidoun Azizi

16

Multi-state analysis of hypertension and mortality: application of semi-Markov model in a longitudinal cohort study

BMC Cardiovascular Disorders 20(1) (2020)

Azra Ramezankhani; Michael J. Blaha; Mohammad hassan Mirbolouk; Fereidoun Azizi; Farzad Hadaegh

17

Association between metabolic score for insulin resistance and clinical outcomes: insights from the Tehran lipid and glucose study

Nutrition & Metabolism 21(1) (2024)

Seyyed Saeed Tamehri Zadeh; Neda Cheraghloo; Soroush Masrouri; Farzad Esmaeili; Fereidoun Azizi; Farzad Hadaegh

18

Sex differences in the association between diabetes and hypertension and the risk of stroke: cohort of the Tehran Lipid and Glucose Study

Biology of Sex Differences 13(1) (2022)

Azra Ramezankhani; Donna Parizadeh; Fereidoun Azizi; Farzad Hadaegh

20

The impact of long-term exposure to PM10, SO2, O3, NO2, and CO on incident dysglycemia: a population-based cohort study

Environmental Science and Pollution Research 30(2) (2022)

Seyed Saeed Tamehri Zadeh; Alireza Khajavi; Azra Ramezankhani; Fereidoun Azizi; Farzad Hadaegh

22

Spousal metabolic risk factors and future cardiovascular events: A prospective cohort study

Atherosclerosis 298 (2020)

Azra Ramezankhani; Kamran Guity; Fereidoun Azizi; Farzad Hadaegh

23

Association of body mass index with life expectancy with and without cardiovascular disease

International Journal of Obesity 44(1) (2019)

Nazanin Fekri; Pegah Khaloo; Azra Ramezankhani; Mohammad Ali Mansournia; Fereidoun Azizi; Farzad Hadaegh

24

The relationship between glucose intolerance status and risk of hospitalization during two decades of follow-up: Tehran lipid and glucose study

Annals of Medicine 54(1) (2022)

Rahele Rasooli; Azra Ramezankhani; Davood Khalili; Maryam Tohidi; Mitra Hasheminia; Fereidoun Azizi; Farzad Hadaegh

26

Contributions and Implications of the Tehran Lipid and Glucose Study

International Journal of Endocrinology and Metabolism 16(4 (Suppl)) (2018)

Fereidoun Azizi; Miralireza Takyar; Azita Zadeh-Vakili

27

The impact of general and central obesity for all-cause hospitalization among Iranian adults: a 20 year follow-up-results from the TLGS cohort

BMC Public Health 23(1) (2023)

Azra Ramezankhani; Fereidoun Azizi; Mitra Hasheminia; Farzad Hadaegh

28

Age and aging effects on blood pressure: 15 years follow‐up of Tehran lipid and glucose study

The Journal of Clinical Hypertension 23(6) (2021)

Alireza Khajavi; Farid Zayeri; Azra Ramezankhani; Amir Nazari; Fereidoun Azizi; Farzad Hadaegh

29

Trajectories of cardiovascular disease risk and their association with the incidence of cardiovascular events over 18 years of follow-up: The Tehran Lipid and Glucose study

Journal of Translational Medicine 19(1) (2021)

Fatemeh Koohi; Nooshin Ahmadi; Farzad Hadaegh; Siavash Safiee; Fereidoun Azizi; Davood Khalili

30

Mean versus variability of lipid measurements over 6 years and incident cardiovascular events: More than a decade follow-up

Frontiers in Cardiovascular Medicine 9 (2022)

Soroush Masrouri; Leila Cheraghi; Niloofar Deravi; Neda Cheraghloo; Maryam Tohidi; Fereidoun Azizi; Farzad Hadaegh

31

Kidney function decline is associated with mortality events: over a decade of follow-up from Tehran Lipid and Glucose Study

Journal of Nephrology 37(1) (2023)

Soroush Masrouri; Seyed Saeed Tamehri Zadeh; Mehdi Pishgahi; Fereidoun Azizi; Michael D. Shapiro; Farzad Hadaegh

32

External validation of the European risk assessment tool for chronic cardio-metabolic disorders in a Middle Eastern population

Journal of Translational Medicine 18(1) (2020)

Samaneh Asgari; Fatemeh Moosaie; Davood Khalili; Fereidoun Azizi; Farzad Hadaegh

33

Impact of Polycystic Ovary Syndrome on Silent Coronary Artery Disease and Cardiovascular Events; A Long-term Population-based Cohort Study

Archives of Medical Research 53(3) (2022)

Fatemeh Mahboobifard; Maryam Rahmati; Atrin Niknam; Ehsan Rojhani; Amir Abbas Momenan; Fereidoun Azizi; Fahimeh Ramezani Tehrani

34

Does Adding Adverse Pregnancy Outcomes Improve the Framingham Cardiovascular Risk Score in Women? Data from the Tehran Lipid and Glucose Study

Journal of the American Heart Association 11(2) (2022)

Marzieh Saei Ghare Naz; Ali Sheidaei; Ali Aflatounian; Fereidoun Azizi; Fahimeh Ramezani Tehrani

35

Sex Differences in Cumulative Exposure to Metabolic Risk Factors Before Hypertension Onset: The Cohort of the Tehran Lipid and Glucose Study

Journal of the American Heart Association 10(23) (2021)

Azra Ramezankhani; Fereidoun Azizi; Amir Abbas Momenan; Farzad Hadaegh

36

Long-term effectiveness of a lifestyle intervention on the prevention of type 2 diabetes in a middle-income country

Scientific Reports 10(1) (2020)

Mojtaba Lotfaliany; Mohamad Ali Mansournia; Fereidoun Azizi; Farzad Hadaegh; Neda Zafari; Arash Ghanbarian; Parvin Mirmiran; Brian Oldenburg; Davood Khalili

37

Changes in Fasting plasma glucose status and risk of mortality events in individuals without diabetes over two decades of Follow-up: a pooled cohort analysis

Cardiovascular Diabetology 21(1) (2022)

Karim Kohansal; Soroush Masrouri; Davood Khalili; Azra Ramezankhani; Fereidoun Azizi; Michael J Blaha; Farzad Hadaegh

38

The clinical value of metabolic syndrome and its components with respect to sudden cardiac death using different definitions: Two decades of follow-up from the Tehran Lipid and Glucose Study

Cardiovascular Diabetology 21(1) (2022)

Soroush Masrouri; Seyyed Saeed Moazzeni; Neda Cheraghloo; Fereidoun Azizi; Farzad Hadaegh